LANGHORNE, Pa., December 22, 2025--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback